microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network

Liming Zhang1, Tan Deng, Xiayu Li

  • 1Cancer Research Institute, Central South University, Changsha, Hunan 410078, China.

Carcinogenesis
|January 8, 2010
PubMed

Insights

MicroRNAs (miRNAs) like miR-141 are altered in nasopharyngeal carcinoma (NPC). Targeting miR-141 impacts NPC cell behavior and may involve a network with c-MYC, SPLUNC1, BRD3, UBAP1, and PTEN.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are small non-coding RNAs implicated in various diseases, including cancer.
  • Nasopharyngeal carcinoma (NPC) is a complex malignancy involving genetic and epigenetic alterations.

Purpose of the Study:

  • To investigate the role of miRNA profiles in NPC.
  • To identify specific miRNAs and their target genes involved in NPC development.

Main Methods:

  • Knockdown of oncogene c-MYC and re-expression of tumor suppressor SPLUNC1 in NPC cells.
  • Analysis of microRNA-141 (miR-141) expression and its functional impact.
  • Luciferase reporter assays and western blotting to validate target genes (BRD3, UBAP1, PTEN).

Main Results:

  • Both c-MYC knockdown and SPLUNC1 re-expression down-regulated miR-141.
  • miR-141 was upregulated in NPC specimens and its inhibition affected NPC cell cycle, apoptosis, growth, migration, and invasion.
  • BRD3, UBAP1, and PTEN were identified as direct targets of miR-141.
  • miR-141 inhibition influenced key molecules in the Rb/E2F, JNK2, and AKT pathways.

Conclusions:

  • miR-141 plays a significant role in NPC pathogenesis.
  • A potential gene-miRNA network involving miR-141, c-MYC, SPLUNC1, BRD3, UBAP1, and PTEN contributes to NPC development.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...